Arbel, Y., Klempfner, R., Erez, A., Goldenberg, I., Benzekry, S., Shlomo, N., . . . Tenenbaum, A. (2016). Bezafibrate for the treatment of dyslipidemia in patients with coronary artery disease: 20-year mortality follow-up of the BIP randomized control trial. Cardiovasc Diabetol.

Arbel, Yaron, Robert Klempfner, Aharon Erez, Ilan Goldenberg, Sagit Benzekry, Nir Shlomo, Enrique Z. Fisman, and Alexander Tenenbaum. "Bezafibrate for the Treatment of Dyslipidemia in Patients With Coronary Artery Disease: 20-year Mortality Follow-up of the BIP Randomized Control Trial." Cardiovasc Diabetol 2016.

Arbel, Yaron, et al. "Bezafibrate for the Treatment of Dyslipidemia in Patients With Coronary Artery Disease: 20-year Mortality Follow-up of the BIP Randomized Control Trial." Cardiovasc Diabetol 2016.